{
    "eid": "2-s2.0-85075427842",
    "title": "Diffuse large B-cell lymphoma variants: an update",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pathology and Forensic Medicine",
            "@code": "2734",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Diffuse large B-cell lymphoma",
        "variants",
        "World Health Organization classification"
    ],
    "authors": [
        "Narittee Sukswai",
        "Kirill Lyapichev",
        "Joseph D. Khoury",
        "L. Jeffrey Medeiros"
    ],
    "citedby-count": 87,
    "ref-count": 116,
    "ref-list": [
        "Diffuse large B-cell lymphoma",
        "T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes",
        "T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management",
        "Utility of combined EZH2, p-ERK1/2, p-STAT, and MYC expression in the differential diagnosis of EZH2-positive Hodgkin lymphomas and related large B-cell lymphomas",
        "Predominance of CD4+ T cells in T-cell/histiocyte-rich large B-cell lymphoma and identification of a subset of patients with peripheral B-cell lymphopenia",
        "T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas",
        "PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma",
        "JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma",
        "Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma",
        "A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation",
        "ALK-positive large B-cell lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature",
        "Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis",
        "Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base",
        "ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements",
        "ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern",
        "ALK-positive large B-cell lymphoma with strong CD30 expression; a diagnostic pitfall and resistance to brentuximab and crizotinib",
        "ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC)",
        "ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases",
        "Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma",
        "Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection",
        "Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point",
        "Plasmablastic lymphoma: current perspectives",
        "The biology and treatment of plasmablastic lymphoma",
        "Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients",
        "Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles",
        "Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients",
        "CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall",
        "Plasmablastic lymphoma involving the penis: a previously unreported location of a case with aberrant CD3 expression",
        "IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas",
        "Intravascular large B-cell lymphoma involving large blood vessels, three autopsy cases",
        "Intravascular large B-cell lymphoma presenting as Richter's syndrome with cerebral involvement in a patient with chronic lymphocytic leukemia",
        "Intravascular large B-cell lymphoma secondary to lymphoplasmacytic lymphoma: a case report and review of literature with clonality analysis",
        "Intravascular large B-cell lymphoma in the United States (US): a population-based study using surveillance, epidemiology, and end results program and national cancer database",
        "Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks",
        "Intravascular large B-cell lymphoma. A report of five cases initially diagnosed by bone marrow biopsy",
        "Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases",
        "High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma",
        "Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors",
        "Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma",
        "Immune evasion-related extranodal large B-cell lymphoma: a report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma",
        "Recurrent cytogenetic abnormalities in intravascular large B-cell lymphoma",
        "Liquid biopsy for the identification of intravascular large B-cell lymphoma",
        "Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe; German High-Grade Lymphoma Study Group; Berlin-Frankfurt-M\u00fcnster-NHL Trial Group. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults",
        "Tonsillar follicular large B-cell lymphoma with IRF4 rearrangement causing sleep apnoea",
        "IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials",
        "Pathology and diagnosis of follicular lymphoma and related entities",
        "High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas",
        "Primary mediastinal large B-cell lymphoma",
        "Racial patterns of patients with primary mediastinal large B-cell lymphoma: SEER analysis",
        "The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome",
        "The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma",
        "Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins",
        "Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma",
        "Performance of a commercially available MAL antibody in the diagnosis of primary mediastinal large B-cell lymphoma",
        "Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma",
        "Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma",
        "Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)",
        "Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma",
        "Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation",
        "Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression",
        "Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma",
        "The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas",
        "Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases",
        "High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type",
        "Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas",
        "Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform",
        "PD-L1 and PD-L2 are differentially expressed by macrophages or tumor cells in primary cutaneous diffuse large B-cell lymphoma, leg type",
        "Genomic analyses identify recurrent alterations in immune evasion genes in diffuse large B-cell lymphoma, leg type",
        "High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type",
        "Mutations of the B-cell receptor pathway confer chemoresistance in primary cutaneous diffuse large B-cell lymphoma leg-type",
        "Primary central nervous system lymphoma: a curable disease",
        "Primary CNS lymphoma",
        "The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma",
        "Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication",
        "Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: analysis of 89 cases",
        "MYC/BCL2 co-expression is a stronger prognostic factor compared with the cell-of-origin classification in primary CNS DLBCL",
        "MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas",
        "Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens",
        "MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type",
        "Analysis of genomic alteration in primary central nervous system lymphoma and the expression of some related genes",
        "The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing",
        "Characterization of genomic alterations in primary central nervous system lymphomas",
        "TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy",
        "Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma",
        "Pyothorax-associated lymphoma: a review of 106 cases",
        "Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients",
        "Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation",
        "Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype",
        "Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation",
        "Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation",
        "EBV-positive B-cell proliferations of varied malignant potential: 2015 SH/EAHP Workshop Report - Part 1",
        "Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation?",
        "Lymphomatoid granulomatosis: insights gained over 4 decades",
        "Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations",
        "Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis",
        "Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus",
        "Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution",
        "Extracavitary/solid variant of primary effusion lymphoma",
        "An intrasinusoidal extracavitary variant of primary effusion lymphoma",
        "HHV8/KSHV-positive lymphoproliferative disorders and the spectrum of plasmablastic and plasma cell neoplasms: 2015 SH/EAHP Workshop Report - Part 3",
        "Cytokeratin-positive primary effusion lymphoma: a diagnostic challenge",
        "Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma",
        "Testicular cancer among US men aged 50 years and older",
        "Primary testicular lymphoma: a SEER analysis of 1,169 cases",
        "The survival and prognostic factors of primary testicular lymphoma: two-decade single-center experience",
        "Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium",
        "The pathobiology of primary testicular diffuse large B-cell lymphoma: implications for novel therapies",
        "Expression of OCT4 and SALL4 in diffuse large B-cell lymphoma: an analysis of 145 consecutive cases and testicular lymphomas",
        "PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma",
        "Primary extranodal diffuse large B-cell lymphomas: many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases",
        "Targetable genetic features of primary testicular and primary central nervous system lymphomas",
        "High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease",
        "Human herpesvirus 8-related diseases: histopathologic diagnosis and disease mechanisms",
        "KSHV induces immunoglobulin rearrangements in mature B lymphocytes",
        "Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}